Advanced Solid Tumors

Researchers from the University of the Sunshine Coast and Medicenna want to trial an investigational treatment for confirmed advanced and/or metastatic solid tumours.

Cancer screening and treatment

Study Purpose/Description

This study aims to understand the effectiveness of an investigational treatment for confirmed advanced and/or metastatic solid tumours.

What’s Involved?

Taking part in this study involves receiving an investigational treatment for confirmed advanced and/or metastatic solid tumours. Participants will be required to visit the University of the Sunshine Coast Clinical Trials Sunshine Coast Haematology and Oncology clinic in Buderim, Queensland every 2 weeks for up to 2 years.

If you are included in the trial, you will receive trial medication or trial medication and pembrolizumab. The investigational treatment will be administered every 2 weeks as an IV infusion (into a vein) over 30-60 minutes. For patients who are assigned to trial medication + pembrolizumab, the pembrolizumab will be administered every 6 weeks as an IV infusion over 30 minutes.

Participation in this study will be free of charge and private health insurance is not required.

If you think you might be eligible and interested you can learn more and complete a screening survey at this link. The clinical trial team will then call you to ask you more questions to determine if this trial is suitable for you.

Recruitment criteria

You may be eligible to participate in this study if you:

Are aged 18 years or above
Are located in QLD
Have had a locally advanced and/or metastatic solid tumour confirmed by a histology or cytology (tissue/cell analysis) report
Can attend treatment every 2 weeks with the study drug(s) for up to 2 years.

Benefits

Participation in this study will be free of charge and private health insurance is not required.

Study sponsor / funder

Research team contacts

Research Team

[email protected]

0421 964 895

The Join Us Register Acknowledges the Traditional Owners of the lands across Australia as the continuing custodians of Country and acknowledge the many Aboriginal and Torres Strait Islander people of this land. We pay our respect to First Nations peoples and Elders, past and present.

We acknowledge and celebrate the knowledge and the strengths of Aboriginal and Torres Strait Islander peoples and communities and recognise their continuing connection to land and waters.

We thank the many Aboriginal and Torres Strait Islander communities, and the many individuals, organisations that have supported and guided us through our journey.

There is a huge opportunity to partner more with Aboriginal and Torres Strait Islander communities to build on existing community strengths and resilience, often in the face of ongoing inequities. Through Join Us, we will work together in the spirit of reciprocity to address ongoing impacts of colonisation so that we can all realise optimal health and wellbeing.

+61 2 8052 4798

[email protected]

The Join Us Register is currently funded by the Australian Stroke and Heart Research Accelerator (ASHRA).

For more information about ASHRA, click here.

Advanced Solid Tumors

Study Purpose/Description

What’s Involved?

Recruitment criteria

Benefits

Study sponsor / funder

Research team contacts

Research Team

Join Us Register

For Participants

For Researchers

Resources

An initiative of

Register your interest